Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology Researchers Explore Role of Neutrophils in Autoimmunity

Susan Bernstein  |  Issue: January 2016  |  January 19, 2016

One physiological stimulator of NETosis may be neutrophil swarming, and this process is intriguing to researchers as well, said Dr. Radic. “Neutrophil swarming is the coordinated gathering of neutrophils. This migration can be induced by infectious pathogens, like toxoplasma, and localized cell death may occur due to trauma or physical injury” that could be the early trigger of inflammation in rheumatic disease, he said. “The signals that induce swarming and the receptors on the neutrophils that allow them to respond are an active area of research. In part, this neutrophil migration is thought to form the basis for subsequent events in inflammation.”

NETosis provides an amplification step in the inflammatory process and promotes pro-inflammatory gene expression, said Dr. Radic. It allows the release of the neutrophils’ granule contents and chromatin.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“There seems to be a mutual relation between NETosis and neutrophil swarming in that neutrophils that undergo NETosis attract even more swarming neutrophils to the site,” said Dr. Radic. “Conversely, swarming seems to predispose cells toward NETosis. So, mutually, these events seem to foment each other.”

Resolving Role

Neutrophils also have strategic and tactical functions, said Martin Herrmann, PhD, scientific group leader, Autoimmunity Research and Cellular Immunology, at Friedrich-Alexander University in Erlangen, Germany.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

NETs play a key role in the induction of gout, and “the resolution phase of inflammation in gout is as important as the induction phase,” he said. If inflammation is not controlled after an infection or injury, it becomes problematic. NETs contribute to the resolution of MSU crystal-induced inflammation in gout. Dr. Herrmann described a vicious circle of activity: neutrophil recruitment, NETosis, and IL-8 release. NETs’ role in gouty inflammation induction and resolution may yield more clues in understanding autoimmunity in general, he said.

In the early phase of this type of gout, MSU crystals induce the formation of NETs and release of pro-inflammatory cytokines and chemokines. “At high neutrophil densities, NETs tend to aggregate. It looks like this is an amorphous material which forms the basis of tophi,” he said. But the cytokine and chemokine release by the aggregated NETs is strongly reduced. The aggregated NETs sequester and degrade these pro-inflammatory mediators. In MSU crystal-induced gout studies in vivo, aggregated NET formation depends on ROS production, he added.

Oxidative burst is required to prevent MSU-induced bone destruction and resolve MSU-induced inflammation, Dr. Herrmann added. Neutrophils and their activity are required for the resolution of inflammation in gout, and he described studies where neutrophils were depleted from mice with paw edema, causing their inflammation and swelling to become chronic.1

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Meeting ReportsResearch Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)autoimmunityneutrophilResearchrheumatologytherapy

Related Articles

    Neutrophil Extracellular Traps & Their Role in Autoimmunity

    May 18, 2018

    Certain medications have been associated for decades with the development of drug-induced autoimmunity. New research published in March 2018 in Arthritis & Rheumatology suggests that NETs (neutro­phil extracellular traps) are potentially implicated in the mechanisms that lead to drug-induced autoimmunity.1 Peter Grayson, MD, MSc, head of the Vasculitis Translational Research Program at the National Institute…

    Aggregated Neutrophils Limit Inflammation

    June 30, 2014

    A new study suggests understanding this antiinflammatory pathway may lead to new immunomodulatory therapy for resolving inflammation

    Pathophysiology of Gouty Tophi

    March 19, 2018

    In a recent study, researchers examined synovial fluid and non-inflamed tophi from the acutely inflamed joints of patients with gout, finding that monosodium urate (MSU) crystals trigger a distinct physiological NETosis pathway that coats MSU crystals in DNA that persists in tissues as gouty tophi…

    B Cell Depletion: The Latest Information on Disease Processes, Therapies

    January 25, 2021

    Experts discussed the latest knowledge on B cell disease processes, and what it might mean for future B cell depletion therapies.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences